if depletion or altered metabolism of pyridoxine by reduced metabolites is also responsible for the neurotoxic effects of nitroimidazoles in humans , then concomitant administration of pyridoxine ( in doses greater than the molar quantity of nh2-miso formed ) should inhibit the development of such symptoms and allow administration of larger doses of miso than are currently clinically employable .
C0028179
nitroimidazoles
C0026218
miso